Benitec Biopharma and Medistem Technologies Successfully Combined in...
SYDNEY, AUSTRALIA and SAN DIEGO, CA -- -- 02/06/12 -- Benitec Biopharma and Medistem announced today the successful treatment of rheumatoid arthritis in preclinical models using Benitec Biopharma's patented gene silencing technology applied to stem cell-derived immune system cells called dendritic cells.
Join the discussion below, or Read more at Sys-Con Media.
#1 Feb 14, 2012
It is a very innovative idea to combine stem cells with siRNA or in benitec's case shRNA
Add your comments below
|Medical Equipment||10 hr||Anonymous||4|
|Can stents help in the bedroom? Medtronic aims ... (Oct '09)||May 19||Allo||25|
|Proposed high-voltage power lines raise fears i... (Apr '09)||May 19||Bop||95|
|electronic hospital bed (May '06)||Apr '15||Anonymous||26|
|Steris in Mexico (Dec '08)||Apr '15||joe bob||6|
|Class action suit targets hernia mesh manufacturer (Feb '10)||Apr '15||Allen||41|
|Hillsborough in hunt for up to 700 Johnson & Jo...||Mar '15||HumanSpirit||1|
Find what you want!
Search Medical Equipment Forum Now
Copyright © 2015 Topix LLC